FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
19/3/401
04-1913fjev1    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Obrosova, I. G.
Right arrow Articles by Szabó, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Obrosova, I. G.
Right arrow Articles by Szabó, C.
The FASEB Journal Express Article doi:10.1096/fj.04-1913fje
Published online December 20, 2004

Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst

Irina G. Obrosova, Jon G. Mabley, Zsuzsanna Zsengellér, Tamara Charniauskaya, Omorodola I. Abatan, John T. Groves, and Csaba Szabó

E-mail contact: obrosoig{at}pbrc.edu

Nitrosative stress, that is, enhanced peroxynitrite formation, has been documented in both experimental and clinical diabetic neuropathy (DN), but its pathogenetic role remains unexplored. This study evaluated the role for nitrosative stress in two animal models of type 1 diabetes: streptozotocin-diabetic mice and diabetic NOD mice. Control (C) and streptozotocin-diabetic (D) mice were treated with and without the potent peroxynitrite decomposition catalyst FP15 (5 mg kg–1 d–1) for 1 wk after 8 wk without treatment. Sciatic nerve nitrotyrosine (a marker of peroxynitrite-induced injury) and poly(ADP-ribose) immunoreactivities were present in D and absent in C and D+FP15. FP15 treatment corrected sciatic motor and hind-limb digital sensory nerve conduction deficits and sciatic nerve energy state in D, without affecting those variables in C. Nerve glucose and sorbitol pathway intermediate concentrations were similarly elevated in D and D+FP15 vs C. In diabetic NOD mice, a 7-day treatment with either 1 or 3 mg kg–1 d–1 FP15 reversed increased tail-flick latency (a sign of reduced pain sensitivity); the effect of the higher dose was significant as early as 3 days after beginning of the treatment. In conclusion, nitrosative stress plays a major role in DN in, at least, type 1 diabetes. This provides the rationale for development of agents counteracting peroxynitrite formation and promoting peroxynitrite decomposition, and their evaluation in DN.

Key words: poly(ADP-ribose) polymerase • streptozotocin-diabetic rats • NOD mice • nerve conduction deficit • tail-flick latency




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. Masood, M. Yi, M. Lau, R. Belcastro, S. Shek, J. Pan, C. Kantores, P. J. McNamara, B. P. Kavanagh, J. Belik, et al.
Therapeutic effects of hypercapnia on chronic lung injury and vascular remodeling in neonatal rats
Am J Physiol Lung Cell Mol Physiol, November 1, 2009; 297(5): L920 - L930.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Pacher and C. Szabo
Role of the Peroxynitrite-Poly(ADP-Ribose) Polymerase Pathway in Human Disease
Am. J. Pathol., July 1, 2008; 173(1): 2 - 13.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. K. Ali, S. Matragoon, B. A. Pillai, G. I. Liou, and A. B. El-Remessy
Peroxynitrite Mediates Retinal Neurodegeneration by Inhibiting Nerve Growth Factor Survival Signaling in Experimental and Human Diabetes
Diabetes, April 1, 2008; 57(4): 889 - 898.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Toth, L. L. Rong, C. Yang, J. Martinez, F. Song, N. Ramji, V. Brussee, W. Liu, J. Durand, M. D. Nguyen, et al.
Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy
Diabetes, April 1, 2008; 57(4): 1002 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. G. Obrosova, V. R. Drel, C. L. Oltman, N. Mashtalir, J. Tibrewala, J. T. Groves, and M. A. Yorek
Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats
Am J Physiol Endocrinol Metab, December 1, 2007; 293(6): E1645 - E1655.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
H.-J. Maeng, M.-H. Kim, H.-E. Jin, S. M. Shin, T. Tsuruo, S. G. Kim, D.-D. Kim, C.-K. Shim, and S.-J. Chung
Functional Induction of P-glycoprotein in the Blood-Brain Barrier of Streptozotocin-Induced Diabetic Rats: Evidence for the Involvement of Nuclear Factor-{kappa}B, a Nitrosative Stress-Sensitive Transcription Factor, in the Regulation
Drug Metab. Dispos., November 1, 2007; 35(11): 1996 - 2005.
[Abstract] [Full Text] [PDF]


Home page
Exp Biol MedHome page
R. C. Poulsen, P. J. Moughan, and M. C. Kruger
Long-Chain Polyunsaturated Fatty Acids and the Regulation of Bone Metabolism
Exp Biol Med, November 1, 2007; 232(10): 1275 - 1288.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. G. Obrosova, O. Ilnytska, V. V. Lyzogubov, I. A. Pavlov, N. Mashtalir, J. L. Nadler, and V. R. Drel
High-Fat Diet Induced Neuropathy of Pre-Diabetes and Obesity: Effects of "Healthy" Diet and Aldose Reductase Inhibition
Diabetes, October 1, 2007; 56(10): 2598 - 2608.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. R. Drel, N. Mashtalir, O. Ilnytska, J. Shin, F. Li, V. V. Lyzogubov, and I. G. Obrosova
The Leptin-Deficient (ob/ob) Mouse: A New Animal Model of Peripheral Neuropathy of Type 2 Diabetes and Obesity
Diabetes, December 1, 2006; 55(12): 3335 - 3343.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Cuzzocrea, E. Mazzon, R. Di Paola, E. Esposito, H. Macarthur, G. M. Matuschak, and D. Salvemini
A Role for Nitric Oxide-Mediated Peroxynitrite Formation in a Model of Endotoxin-Induced Shock
J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 73 - 81.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Tao, X. Jiao, E. Gao, W. B. Lau, Y. Yuan, B. Lopez, T. Christopher, S. P. RamachandraRao, W. Williams, G. Southan, et al.
Nitrative Inactivation of Thioredoxin-1 and Its Role in Postischemic Myocardial Apoptosis
Circulation, September 26, 2006; 114(13): 1395 - 1402.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
O. Ilnytska, V. V. Lyzogubov, M. J. Stevens, V. R. Drel, N. Mashtalir, P. Pacher, M. A. Yorek, and I. G. Obrosova
Poly(ADP-Ribose) Polymerase Inhibition Alleviates Experimental Diabetic Sensory Neuropathy
Diabetes, June 1, 2006; 55(6): 1686 - 1694.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. G. Obrosova, V. R. Drel, P. Pacher, O. Ilnytska, Z. Q. Wang, M. J. Stevens, and M. A. Yorek
Oxidative-Nitrosative Stress and Poly(ADP-Ribose) Polymerase (PARP) Activation in Experimental Diabetic Neuropathy: The Relation Is Revisited
Diabetes, December 1, 2005; 54(12): 3435 - 3441.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
F. Li, V. R. Drel, C. Szabo, M. J. Stevens, and I. G. Obrosova
Low-Dose Poly(ADP-Ribose) Polymerase Inhibitor-Containing Combination Therapies Reverse Early Peripheral Diabetic Neuropathy
Diabetes, May 1, 2005; 54(5): 1514 - 1522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by The Federation of American Societies for Experimental Biology.